2023 version of the Swiss CHOP code nomenclature published

26

Aug 2022

On July 29, 2022, the Swiss Federal Statistics Office (UFS) published the 2023 version of the procedure code (CHOP) nomenclature in the German language. The version in the Italian and French languages will be published in October 2022.

Some examples of newly introduced codes per technology group are provided below:

Cardiovascular

  • 35.F2.26 Mitral valve replacement by xenograft (bioprosthesis) with transapical anchorage
  • 35.H2.26 Removal of mitral valve prosthesis and implantation of xenograft (bioprosthesis) with transapical anchorage
  • 35.H2.25 Removal of mitral valve prosthesis and xenograft (bioprosthesis) implantation, transapical using a percutaneous apical access and closure system

Endoscopy

  • 32.2A.13 Local excision of lesion or tissue on lung, endoscopic
  • 45.05 Conversion of percutaneous [endoscopic] gastrostomy [PEG] to percutaneous [endoscopic] jejunostomy [PEJ]

Gastrointestinal

  • 52.95.A2 Removal of a stent [prosthesis] from the pancreatic duct, laparoscopic
  • 52.95.A1 Removal of a stent [prosthesis] from the pancreatic duct, open surgical
  • 52.93.30 Endoscopic removal of stent [prosthesis] from pancreatic duct

In-vitro diagnostics

  • 52.11.12 Fine-needle biopsy of the pancreas, endosonographic
  • 52.11.09 Closed [aspiration] [needle] biopsy of pancreas, other

Interventional radiology

  • 00.4A.47 Deployed endovascular extended coils, 6 Extended coils
  • 00.99.AA Radiofrequency and microwave ablation
  • 00.99.A2 Irreversible electroporation
  • 00.99.A5 Ultrasound-guided Focused Ultrasound Surgery [USgFUS]

Nephrology and urology

  • 55.3Y Local excision and destruction of lesion or tissue on kidney, other
  • 55.3A.14 Local excision and destruction of lesion or tissue at kidney, percutaneous-transrenal
  • 55.30 Local excision and destruction of lesion or tissue of kidney, not otherwise specified

Neurology and neurosurgery

  • 02.98.13 Implantation or replacement of a fully implantable infusion pump for intraventricular infusion with integrated electronic occlusion monitoring
  • 03.9B.13 Implantation or replacement of a fully implantable infusion pump for intrathecal and epidural infusion with integrated electronic occlusion monitoring

Obstetrics and gynecology

  • 68.29.4B Excision and destruction of one or more uterine fibroids, transcutaneous
  • 68.29.48 Excision and destruction of one or more uterine fibroids, laparoscopic

Orthopedics

  • 00.9E One-stage multiple interventions on muscles and tendons in the arm and leg for contractures
  • 77.31.13 Complex (multidimensional) osteotomy (with axis correction) on the clavicle
  • 82.72.21 Transplantation of other flap graft with microvascular anastomosis of muscle or fascia to the hand

Peripheral vascular

  • 39.25.16 Aorto-ilio-popliteal bypass

Pulmonary and airways

  • 32.2A.14 Local excision and destruction of lesion or tissue on lung, percutaneous
  • 32.2A.13 Local excision of lesion or tissue on lung, endoscopic

Surgical procedures

  • 54.69 Abdominal wall suture, other
  • 54.99.51 Opening and reapplication of a temporary abdominal wall closure

See the 2023 CHOP nomenclature in German here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

06

Jun 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2023. Twenty-one recommendations were published in relation to the registration, modification of registration conditions, and renewal of registration for devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular and peripheral vascular, endocrine, ENT, gastrointestinal, and orthopedic devices, as well as medical aids.

Read more

01

Jun 2023

On May 23, 2023, the Ministry of Health and Prevention published an Order in the Official Journal of the French Republic setting the tariffs for the medical telemonitoring activities covered by social health insurance in the context of the new framework. The tariffs will differ whether they bring an organizational or clinical (improvement in quality of life, morbidity, or mortality) benefit.

Read more

29

May 2023

On May 17, 2023, the Ministry of Health and Prevention published the 2023-2027 Digital Health Roadmap. The new roadmap specifies the priorities and the projects to be carried out by 2027. One of the key objectives is to support the implementation and extension of telemonitoring to more chronic pathologies.

Read more

26

May 2023

In late May 2023, the Norwegian Directorate of e-Health released an updated version of the Norwegian Laboratory code (NLK) system to be implemented no later than July 1, 2023. A total of 142 new codes were added, 33 codes were terminated, and 122 codes were amended.

Read more

25

May 2023

On May 17, 2023, NHS England issued an updated version of the National Genomic Test Directory for cancer, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Two new codes (test-indication combinations) were introduced.

Read more